150 related articles for article (PubMed ID: 10235470)
1. The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors.
Grothey A; Voigt W; Schöber C; Müller T; Dempke W; Schmoll HJ
J Cancer Res Clin Oncol; 1999; 125(3-4):166-73. PubMed ID: 10235470
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
[TBL] [Abstract][Full Text] [Related]
3. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
Rubin R; Baserga R
Lab Invest; 1995 Sep; 73(3):311-31. PubMed ID: 7564264
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.
Hua H; Kong Q; Yin J; Zhang J; Jiang Y
J Hematol Oncol; 2020 Jun; 13(1):64. PubMed ID: 32493414
[TBL] [Abstract][Full Text] [Related]
6. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor I receptor: a key to tumor growth?
Baserga R
Cancer Res; 1995 Jan; 55(2):249-52. PubMed ID: 7812953
[TBL] [Abstract][Full Text] [Related]
8. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
9. The insulin-like growth factor system and cancer.
LeRoith D; Roberts CT
Cancer Lett; 2003 Jun; 195(2):127-37. PubMed ID: 12767520
[TBL] [Abstract][Full Text] [Related]
10. The IGF-1 receptor in cancer biology.
Baserga R; Peruzzi F; Reiss K
Int J Cancer; 2003 Dec; 107(6):873-7. PubMed ID: 14601044
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
[TBL] [Abstract][Full Text] [Related]
12. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.
Reinmuth N; Liu W; Fan F; Jung YD; Ahmad SA; Stoeltzing O; Bucana CD; Radinsky R; Ellis LM
Clin Cancer Res; 2002 Oct; 8(10):3259-69. PubMed ID: 12374697
[TBL] [Abstract][Full Text] [Related]
13. Autocrine stimulation by insulin-like growth factor I is involved in the growth, tumorigenicity and chemoresistance of human esophageal carcinoma cells.
Liu YC; Leu CM; Wong FH; Fong WS; Chen SC; Chang C; Hu CP
J Biomed Sci; 2002; 9(6 Pt 2):665-74. PubMed ID: 12432233
[TBL] [Abstract][Full Text] [Related]
14. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling.
Romano G; Prisco M; Zanocco-Marani T; Peruzzi F; Valentinis B; Baserga R
J Cell Biochem; 1999 Feb; 72(2):294-310. PubMed ID: 10022512
[TBL] [Abstract][Full Text] [Related]
16. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
Kuo WW; Liu CJ; Chen LM; Wu CH; Chu CH; Liu JY; Lu MC; Lin JA; Lee SD; Huang CY
Apoptosis; 2006 Jul; 11(7):1075-89. PubMed ID: 16699953
[TBL] [Abstract][Full Text] [Related]
18. Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells.
Giuliano M; Vento R; Lauricella M; Calvaruso G; Carabillo M; Tesoriere G
Eur J Biochem; 1996 Mar; 236(2):523-32. PubMed ID: 8612625
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
20. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
Kim EJ; Shin HK; Park JH
J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
